Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study

Figure 2

Mean HbA1c (%) at baseline and at end of study (logarithmic regression model, chi-square test).